Description
VHA BREAST CANCER MOLECULAR TESTING ORDER 2
First action · last action
2025-08-20 · 2026-08-19
Transactions
3
First transaction's obligation
$566,449
Base + all options value (sum of deltas)
$1,481,749
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C10X24A0011
NAICS
621511 · MEDICAL LABORATORIES
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-08-20+$566,449= $566,449
- Mod P000012026-04-23+$417,929= $984,379
- Mod P000022026-08-19+$497,370= $1,481,749
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-08-20 | +$566,449 | $566,449 | VHA BREAST CANCER MOLECULAR TESTING ORDER 2 |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-04-23 | +$417,929 | $984,379 | VHA BREAST CANCER MOLECULAR TESTING ORDER 2 |
| Mod P00002· EXERCISE AN OPTION | 2026-08-19 | +$497,370 | $1,481,749 | VHA BREAST CANCER MOLECULAR TESTING ORDER 2 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NGBXEJX5GLE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0419 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $127,174 | FY2026 |
| 36C25726N0252 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $52,215 | FY2026 |
| 36C25526N0057 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0056 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0054 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $24,259 | FY2026 |
| 36C25526N0055 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,116 | FY2026 |
Other recipients under Q301 from SAC FREDERICK (36C10X) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C10X25N0264 | BAYLOR MIRACA GENETICS LABORATORIES LLC | SAC FREDERICK (36C10X) | $11,387,675 | FY2025 |
| 36C10X25N0265 | FULGENT THERAPEUTICS LLC | SAC FREDERICK (36C10X) | $6,573,600 | FY2025 |
| 36C10X24N0227 | FULGENT THERAPEUTICS LLC | SAC FREDERICK (36C10X) | $2,949,000 | FY2024 |
| 36C10X24D0028 | FULGENT THERAPEUTICS LLC | SAC FREDERICK (36C10X) | $0 | FY2024 |
| 36C10X24N0226 | BAYLOR MIRACA GENETICS LABORATORIES LLC | SAC FREDERICK (36C10X) | $344,429 | FY2024 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C10X25F0038_3600_36C10X24A0011_3600 · retrieved 2026-09-26.